BioMimetic Therapeutics

Venture Notebook: Noro-Moseley will keep eye on Digital Media

Oct 08, 2009 at 02:03 pm by miltcapps

The news last week that Noro-Moseley Partners and digital-media specialist and General Partner Greg Foster had parted ways may have sent an uncertain message to Nashville medi.... Read More

Leaders: Bio-entrepreneur sees leverage in TNInvestco

Oct 08, 2009 at 01:08 pm by miltcapps

Life-sciences entrepreneur and investor Joe Cook Jr. has made clear he wants to devote more energy to helping grow Tennessee's life-sciences sector. Although Cook has thus far.... Read More

Mulron: Digital Nashville loves its independence, diversity

Sep 02, 2009 at 11:39 am by miltcapps

Digital Nashville, the online and on-the-ground community, now has about 2,000 registrants and will soon expand its programs and services. DN Co-Founder and Managing Director.... Read More

TN Biotech group confirms its new chair's resignation

Aug 31, 2009 at 11:10 pm by miltcapps

Tennessee Biotechnology Association yesterday confirmed that its recently appointed chairwoman has resigned from the organization. Leslie Wisner-Lynch, DDS, DMSc, a former me.... Read More

Dream Systems founder targets healthcare technology

Aug 11, 2009 at 04:54 pm by miltcapps

[Editor's note: Terriance Moody died May 9, 2019. Obit here.] A company's world vision depends partly on its prism: Within Dream Systems LLC, the prism is video, and the world.... Read More

Cumberland IPO now active: 10-year journey with Vanderbilt reaches milestone

Aug 07, 2009 at 09:51 am by miltcapps

UPDATED Aug. 11, 6:45 a.m.:  Cumberland Pharmaceuticals [NASDAQ:CPIX] went effective 3 p.m. Aug. 10 and is listed this morning as CPIX on NASDAQ. The share price was set.... Read More

Belmont University aims to raise Business enrollment

Jan 21, 2009 at 10:52 pm by miltcapps

Belmont University is preparing to provide students a faster path to an MBA. The university's pending "5th Year" offering that will for the first time allow Belmont undergrad.... Read More

Brain Gain: Bio Business Plan deadline to be extended

Jan 18, 2009 at 04:25 pm by miltcapps

To attract more student entrants, Tennessee Biotechnology Association is extending the deadline for entries in TBA's 2nd Annual Student/PostDoc Business Plan Competition. Eric.... Read More

Stakes are rising for TTDC, as VC group presses for change

Nov 28, 2008 at 02:50 pm by miltcapps

Feelings run deep among venture-capital executives who believe the state is doing far too little to advance high-growth sectors of the Tennessee economy. In the face of that e.... Read More

MB Ventures' 3rd fund emerging in time to reap 'Vintage 2009' values

Nov 25, 2008 at 09:30 am by miltcapps

Visiting Nashville last week, Gary Stevenson was tight-lipped about plans for MB Venture Partners' rumored third fund. The only comment the MBVP managing partner would utter i.... Read More

Credibility Crunch: Health M&A and innovation shaped by Feds

Sep 17, 2008 at 09:04 am by miltcapps

No matter who's in The White House during the next three years, financial, economic and regulatory pressures will probably make life sciences, rather than healthcare services.... Read More

Bionic Woman: Exec perseveres, while biotech struggles for momentum

Sep 14, 2008 at 04:45 pm by miltcapps

Leslie Wisner-Lynch, DDS, DMSc, hesitated only briefly when asked in a recent VNC interview whether it's true she picked Nashville as the new home for BioMimetic Therapeutics,.... Read More

Gordon-Wamp give fresh push to Mid-TN Tech consortium

Sep 02, 2008 at 06:57 am by miltcapps

A fledgling Middle Tennessee advocate for technology-driven growth got fresh bipartisan impetus yesterday, when the Tennessee Valley Corridor, a multistate economic and tech-d.... Read More

Strategy notes: Family advisers shape investments

Aug 14, 2008 at 12:47 pm by miltcapps

BioMimetic shakes-off FDA bruise,<Br> carves-out Biotechnology niche

May 16, 2008 at 12:53 am by miltcapps

Updated March 1, 2013: Wright Medical completed its acquisition of BioMimetic, in a transaction valued at $190MM or more. Release here.-Ed. BioMimetic Therapeutics provides a.... Read More

Get the Newsletter